These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2143754)

  • 1. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
    Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC
    Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: iodobenzamide and iodoethylspiperone.
    Pellevoisin C; Chalon S; Zouakia A; Dognon AM; Frangin Y; Baulieu JL; Besnard JC; Guilloteau D
    Life Sci; 1993; 52(23):1851-60. PubMed ID: 8502122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECT.
    Ballinger JR; Gulenchyn KY; Hassan MN
    Int J Rad Appl Instrum A; 1989; 40(6):547-9. PubMed ID: 2551854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain.
    Kung HF; Billings JJ; Guo YZ; Mach RH
    Int J Rad Appl Instrum B; 1988; 15(2):203-8. PubMed ID: 2966783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of 123I-labeled 2'-iodospiperone and imaging of D2 dopamine receptors in the human brain using SPECT.
    Saji H; Iida Y; Magata Y; Yonekura Y; Iwasaki Y; Sasayama S; Konishi J; Nakatsuka I; Shiba K; Yoshitake A
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):523-9. PubMed ID: 1399682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
    Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
    Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
    J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.
    Crawley JC; Crow TJ; Johnstone EC; Oldland SR; Owen F; Owens DG; Smith T; Veall N; Zanelli GD
    Nucl Med Commun; 1986 Aug; 7(8):599-607. PubMed ID: 2946010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
    Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF; Pan S; Kung MP; Billings J; Kasliwal R; Reilley J; Alavi A
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
    Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
    J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
    Kung MP; Kung HF; Billings J; Yang Y; Murphy RA; Alavi A
    J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.
    Mazière B; Loc'h C; Baron JC; Sgouropoulos P; Duquesnoy N; D'Antona R; Cambon H
    Eur J Pharmacol; 1985 Aug; 114(3):267-72. PubMed ID: 3877639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
    Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated 2'-iodospiperone: a new radioligand for in vivo dopamine receptor study.
    Saji H; Nakatsuka I; Shiba K; Tokui T; Horiuchi K; Yoshitake A; Torizuka K; Yokoyama A
    Life Sci; 1987 Oct; 41(17):1999-2006. PubMed ID: 3669906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.